Inotuzumab (Anti-Siglec-2 / CD22)
Inotuzumab (Anti-Siglec-2 / CD22) is a humanized IgG4, κ monoclonal antibody that targets CD22. Inotuzumab can be used for the research of acute lymphoblastic leukaemia and non-Hodgkin lymphoma. MW : 144.78 kD.
| Trivial name | Humanized Anti-CD22 Recombinant Antibody |
| Catalog Number | A2358 |
| CAS# | 1660159-36-3 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/inotuzumab-anti-siglec-2-cd22.html |